Welcome to our dedicated page for MARSH & MCLENNAN COMPANIES SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARSH & MCLENNAN COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARSH & MCLENNAN COMPANIES's regulatory disclosures and financial reporting.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) reported that Katherine Brennan, its Senior Vice President and General Counsel, exercised employee stock options covering 1,197 shares of common stock on September 2, 2026 at an exercise price of $83.046 per share, then sold 1,197 shares of common stock at $187.899 per share the same day. The underlying options, granted on February 21, 2018 and vesting annually from 2019 through 2022, are now fully exercised with no shares remaining from that grant, and no Rule 10b5-1 trading plan is reported for these transactions.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) reported that President and CEO John Q. Doyle exercised stock options for 16,656 shares of common stock on September 2, 2026 at an exercise price of $73.195 per share, converting previously granted options into shares.
On the same date, he sold 16,656 shares of common stock at a reported price of $188.51 per share. The filing states that these transactions were effected pursuant to a previously adopted Rule 10b5-1 trading plan, indicating they were pre-arranged rather than opportunistic.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) received a Rule 144 notice for a proposed sale of restricted or control securities. Officer Katherine J. Brennan, through Fidelity Brokerage Services LLC, plans to sell 1,197 shares of common stock on or after September 2, 2026, following a stock option exercise.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) is the issuer for a planned resale of common stock under Rule 144 by John Q. Doyle. The notice covers 16,656 shares of common stock held at Fidelity Brokerage Services LLC, with sales related to a stock option exercise expected on September 2, 2026.
Marsh & McLennan Companies, Inc. (MRSH) director Morton O. Schapiro reported two equity compensation transactions involving restricted stock units that convert into common stock on a 1-for-1 basis. On August 15, 2026, he received 218.9 restricted stock units as a grant of director fees under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $188.445 per unit. On August 14, 2026, he acquired an additional 473.39 restricted stock units through dividend equivalents credited to his account under the same plan at a reference price of $189.15 per unit. Both awards are reported as directly owned and are derivative securities linked to common stock.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Anthony Anderson reported an other acquisition of derivative securities tied to common stock. On 2026-08-14, he acquired 89.41 Restricted Stock Units under the Directors Stock Compensation Plan through dividend equivalents, which convert into common stock on a 1-for-1 basis. Following this transaction, his directly held derivative position under this plan totals 17,171.56 units. These RSUs are reported at a reference value of $189.15 per unit, and the filing does not indicate use of a Rule 10b5-1 trading plan.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Deborah C. Hopkins reported an acquisition of derivative equity under the company’s directors stock plan. On 2026-08-14, she acquired 112.08 Restricted Stock Units labeled "Restricted Stk. Units-Dir. Stk. Plan," which convert into Marsh & McLennan common stock on a 1-for-1 basis. These units were credited as dividend equivalents under the Marsh & McLennan Companies Directors Stock Compensation Plan. Following this transaction, Hopkins directly holds a reported total of 21,526.64 restricted stock units linked to common stock.
MARSH & MCLENNAN COMPANIES, INC. director Tamara Ingram reported an acquisition of 47.56 restricted stock units under the Directors Stock Compensation Plan on 2026-08-14. These units were acquired as dividend equivalents and each unit converts into one share of common stock on a 1-for-1 basis, bringing her directly held restricted stock unit balance to 9,133.91 units.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Lloyd M. Yates reported two acquisitions of restricted stock units under the company’s Directors Stock Compensation Plan. On August 15, 2026, he received 223.73 RSUs tied to director fees, and on August 14, 2026, he received 64.85 RSUs as dividend equivalents. Each unit converts into one share of common stock.
MARSH & MCLENNAN COMPANIES, INC. (symbol MRSH) reports that director Jane H Lute received equity-based compensation in the form of restricted stock units under the company’s Directors Stock Compensation Plan. On 2026-08-15, she was granted 144.27 restricted stock units, and on 2026-08-14 she acquired an additional 46.64 units credited as dividend equivalents. Each unit converts into one share of common stock according to the plan terms.